2.Surgical management of neonate lip and palate cleft.
Wei-min SHEN ; Jie CUI ; Jian-bing CHEN ; Shun-rong WANG
Chinese Journal of Plastic Surgery 2006;22(2):92-94
OBJECTIVETo explore the security and feasibility in ambi-operation of the neonate lip and palate cleft correction.
METHODSUsing Ornizuka's and innovated Langenbeck's method to correct the lip and palate cleft in 30 cases with detailed program, the effect after operation was evaluated.
RESULTSAll physiological index were normal in the group of ambi-operation, which had no difference to other newborn. The effect is satisfactory. 5 of them have the fistula under the gingival.
CONCLUSIONSBased on controlling on surgery indication, screening the well-developed newborn, it is secure and feasible to correct lip and palate in one stage, and it can get excellent effect.
Cleft Lip ; surgery ; Cleft Palate ; surgery ; Feasibility Studies ; Female ; Humans ; Infant, Newborn ; Male ; Reconstructive Surgical Procedures ; methods
3.Analysis on factors influencing one-year-survival of hepatocellular carcinoma patients after hepatectomy
Liqun WU ; Zusen WANG ; Weiyu HU ; Bing HAN ; Jingyu CAO ; Weidong GUO ; Bin ZHANG ; Fabo QIU ; Shun ZHANG
Chinese Journal of General Surgery 2012;27(2):92-95
Objective To analyze the factors that influence the survival condition during the first year after hepatectomy in patients with hepatocellular carcinoma (HCC). Methods Five hundred twentyeight HCC cases undergoing hepatectomy were included from January 1997 to December 2008.The factors and survival outcomes in these patients were analyzed. Results There were 302 patients dying during a medium follow-up of 35 months and 1-year cumulative survival was 85%.The causes of death during first year were tumor recurrence (78.1%,75/96) and liver dyscompensation ( 19.8%,19/96).By Cox regression analysis,tumor size ≥5 cm (P =0.047 ),vascular invasion ( P =0.018),histologic moderately and poorly differentiation ( P =0.001 ) and pathologically positive margin ( P =0.004 ) were significantly associated with tumor recurrence,and portal hypertension was an independent factor for patients dying from liver dysfunction ( P =0.001 ).Positive tumor margin was the most important factor associated with postoperative death within one year (59.3%,60/96). Conclusions During the first year after HCC resection,tumor recurrence and liver dysfunction are main factors influencing HCC patients' survival,nonR0 resection is the main factor causing tumor recurrence,and portal hypertension is an independent factor for patients dying of liver dyscompensation.
4.Prognosis of patients with huge hepatocellular carcinoma after R0 resection
Liqun WU ; Bin ZHANG ; Weidong GUO ; Jingyu CAO ; Zusen WANG ; Weiyu HU ; Bing HAN ; Fabo QIU ; Shun ZHANG
Chinese Journal of Hepatobiliary Surgery 2012;18(8):597-600
Objective To study the prognosis of patients with huge hepatocellular carcinoma (HCC) after R0 resection.Methods 517 patients with primary HCC who underwent R0 resection from January 1997 to December 2008 at the Affiliated Hospital of Medical College Qingdao University were analyzed retrospectively.Results The 5-and 10-years overall survivals (OS) in patients with huge HCC (≥10 cm; n=69) and in patients with HCC <10 cm (n=448) were 24%,18% and 49%,30%,respectively.The median OS was 23.0 and 58.0 month (P<0.001,log rank test) ; and the median disease-free survivals (DFS) were 15.3 and 34.8 month (P<0.001),respectively.The recurrence rate within the first year and the extrahepatic recurrence after resection in patients with huge HCC was significantly higher than in patients with HCC <10 cm (44.9% vs.24.3%,P=0.022;32.7% vs.16.0%,P=0.004).Independent poor prognostic factors of OS and DFS for patients with huge HCC after R0 resection were portal hypertension and vascular invasion.Preoperative transcatheter arterial chemoembolization (TACE) was an independent prognostic factor for better DFS.Conclusions Surgical resection for huge HCC is safe and feasible.For huge HCC after resection,portal hypertension and vascular invasion were poor prognostic factors.Preoperative TACE improved DFS after resection.
5.Effect of annonaceous acetogenin mimic AA005 on proliferative inhibition of leukemia cells in vitro and its possible mechanisms.
Bing HAN ; Zhu-Jun YAO ; Li-Shun WANG
Journal of Experimental Hematology 2012;20(3):549-553
This study was aimed to investigate the biological behavior of annonaceous acetogenin mimic AA005 in various kinds of leukemia cells and further elaborated its possible mechanisms in acute promyelocytic leukemia (APL) cell line NB4. The proliferative inhibition of leukemia cells was measured by CCK-8 method. Cell death was determined by trypan blue. Cell morphological features of NB4 treated with AA005 were examined by microscopy after Wright's staining. The form of cell death was measured by flow cytometry. Proteins PARP-1 and caspase-3 were detected by Western blot. Flow cytometry was used to detect the cell cycle arrest induced by AA005 of low concentration. The results showed that AA005 (> 200 nmol/L) significantly inhibited proliferation of all tested leukemia cell lines in a concentration-dependent manner. The vast majority of cells went to die after leukemia cell lines of NB4, U937 and K562 were treated with different concentration of AA005 for 48 h. Typical morphologic changes significantly appeared in NB4 cells after AA005 treatment. AA005 almost simultaneously induced early apoptosis and late apoptosis. The little cleavage of PARP-1 and activation of caspase-3 happened in AA005-induced cell death, and caspase-3 inhibitor Z-VAD-fmk could not block the cell death. The non-toxic concentrations of AA005 (< 200 nmol/L) caused NB4 cells G(2)/M-phase arrest. It is concluded that annonaceous acetogenin mimic AA005 induces significant proliferative inhibition of various leukemia cell lines in a concentration-dependent manner, which may be associated with cell death and G(2)/M-phase arrest induced by AA005.
Acetogenins
;
pharmacology
;
Apoptosis
;
drug effects
;
Caspase 3
;
metabolism
;
Cell Cycle Checkpoints
;
Cell Proliferation
;
drug effects
;
Fatty Alcohols
;
pharmacology
;
HL-60 Cells
;
Humans
;
K562 Cells
;
Lactones
;
pharmacology
;
Poly (ADP-Ribose) Polymerase-1
;
Poly(ADP-ribose) Polymerases
;
metabolism
6.Antitumor effect research progress of shikonin and its derivatives.
Meng-Yuan ZHU ; Ru-Bing WANG ; Wen ZHOU ; Shao-Shun LI
Acta Pharmaceutica Sinica 2012;47(5):588-593
Shikonin, the main active ingredient of Lithospermum, and its derivatives have been proved to have antitumor effects, and the anti-tumor mechanisms involve multiple targets. Based on recent literatures, this review focuses on the antitumor effects and its mechanisms. More emphases are given on the aspects of induction of apoptosis, induction of necrosis, acting on matrix metalloproteinase, acting on the protein tyrosine kinase and antiangiogenesis. The current status and problems of shikonin derivatives in antitumor effects are simply summarized and lookout for the development of antitumor drugs with shikonin as leading compounds.
Antineoplastic Agents, Phytogenic
;
isolation & purification
;
pharmacology
;
therapeutic use
;
Apoptosis
;
drug effects
;
Cell Line, Tumor
;
Drugs, Chinese Herbal
;
isolation & purification
;
pharmacology
;
therapeutic use
;
Humans
;
Lithospermum
;
chemistry
;
Matrix Metalloproteinase 9
;
metabolism
;
Naphthoquinones
;
isolation & purification
;
pharmacology
;
therapeutic use
;
Necrosis
;
Neoplasms
;
drug therapy
;
metabolism
;
pathology
;
Neovascularization, Pathologic
;
prevention & control
;
Plants, Medicinal
;
chemistry
;
Protein-Tyrosine Kinases
;
metabolism
;
Reactive Oxygen Species
;
metabolism
7.Transumbilical laparoendoscopic single-site surgery in the treatment of neonatal intestinal atresia and stenosis.
Bing LI ; Wei-bing CHEN ; Shou-qing WANG ; Shun-lin XIA ; Shu-li LIU ; Long LI
Chinese Journal of Gastrointestinal Surgery 2013;16(1):44-47
OBJECTIVETo summarize the experiences and advantages of laparoendoscopic single-site (LESS) surgery for neonatal intestinal atresia and stenosis.
METHODSTwenty patients of neonatal intestinal atresia and stenosis were treated with LESS procedure in Huai'an Women and Children's Hospital of Jiangsu Province between October 2010 and April 2012. The clinical data were retrospectively analyzed.
RESULTSAmong these patients, 13 were male, 7 were female. Age at admission ranged from 10 min to 1 d. Four cases were premature, and 3 were born with low birth weight (<2500 g). One was diagnosed with duodenal atresia, 1 with duodenal stenosis, 9 with jejunal atresia, 2 with jejunal stenosis, and 7 with ileal atresia. Laparoscopic exploration was performed in all the cases by transumbilical procedure, the proximal and distal ends were exteriorized from the umbilical port site for anastomosis. Twenty neonates with intestinal atresia and stenosis were performed using this new minimally invasive approach, with no cases converted to open operation or standard laparoscopy. The operative time was 35-60 (mean, 40) min. The intraoperative bleeding was 3-5 ml. Two cases were given up treatment by their parents on the second postoperative day. For the other 18 patients, oral intake started on postoperative day 5-10 (mean, 7), and discharged from hospital on the postoperative day 10-20 (mean, 13). The follow up ranged from 1 to 11 months, during which 1 case died, 3 cases were managed with conservative treatment for diarrhea or malnutrition. The other 14 cases grew up healthily.
CONCLUSIONThe technique of LESS in the treatment of neonatal atresia and stenosis is simple and the outcomes are satisfactory.
Constriction, Pathologic ; surgery ; Female ; Humans ; Infant, Newborn ; Intestinal Atresia ; surgery ; Laparoscopy ; methods ; Male ; Retrospective Studies
8.Microsurgical treatment of Arnold-Chiari Ⅰ malformation combined with syringomyelia
Chang-Shun BAO ; Fu-Bing YANG ; Liang LIU ; Bing WANG ; Shu-Liang ZHAN ; Li-Gang CHEN
Chinese Journal of Neuromedicine 2011;10(10):993-995
Objective To investigate the methods ofmicrosurgical treatment of Arnold-Chiari Ⅰ malformation combined with syringomyelia and their curative effects.Methods The clinical data of 185 patients with Arnold-Chiari Ⅰ malformation combined with syringomyelia,admitted to our hospital from January 1997 to June 2010 and received different surgical treatments,were summarized.The relationship between curative effects and operative methods were analyzed.Results When these 185 patients were discharged from our hospital,the clinical signs and symptoms eliminated in 156 (84.3%)and not changed in 29; no symptomatic deterioration and death were noted.One hundred and forty-seven patients were followed up for 3 months-12 years; symptoms disappeared or alleviated in 110 (74.8%),not changed in 26 and deteriorated in 11.The MR findings in 95 patients demonstrated that the cisternals reconstructed and expanded in 82 and the cavities in spinal cords reduced in 79.Conclusion Both posterior fossa decompression + duraplasty and removal of cerebella tonsils + plastic operation of cistern magna are effective and advisable methods in the treatment of Arnold-Chiari Ⅰ malformation combined with syringomyelia.
9.Solute clearance characteristics of REXEEDTM series dialyzer during high-flux dialysis
Yong-mei, WANG ; Wei-ming, ZHANG ; Bing-shun, WANG ; Ren-hua, LU ; Yan, FANG ; Hui-li, DAI ; Rong, JIANG ; Wen-ying, YU ; Yu-cheng, YAN ; Jia-qi, QIAN
Journal of Shanghai Jiaotong University(Medical Science) 2009;29(7):858-861
Objective To evaluate the solute clearance characteristics of REXEEDTM series dialyzers during high-flux dialysis, and explore the care characteristics. Methods A randomized crossover study of 3×3 Latin square was designed based on different dialyzers. Eighteen patients with regular hemodialysis underwent dialysis with REXEEDTM-15AC dialyzer, REXEEDTM-15UC dialyzer and controlled APS-15U dialyzer, respectively. Blood samples were obtained from the blood flow entrance and exit of dialyzers, levels of urea nitrogen, creatinine, phosphate and β2-microglobulin were detected, and solute clearance rates were calculated. Before and after the third dialysis with each dialyzer, blood samples were obtained to measure the levels of urea nitrogen and creatinine, and the rates of decrease were calculated. The vital signs of each patient were intensively observed, and the venous pressure and transmembrane pressure were monitored from the dialyzers. Results The urea nitrogen clearance rates of REXEEDTM-15AC dialyzer and REXEEDTM-15UC dialyzer were significantly higher than that of APS-15U dialyzer (P<0.05). The creatinine clearance rate of REXEEDTM-15AC dialyzer was significantly higher than that of APS-15U dialyzer(P<0.05). There was no significant difference in the rate of decrease in blood urea nitrogen among different dialyzers of the same patient(>65 % for all patients). The vital signs were stable with no adverse events during dialysis, and there was no abnormal findings in laboratory security parameters. Conclusion REXEEDTM series dialyzers are effective and safe for clinical application. Great importance should be attached to the complaints from patients during dialysis. For those with less ultrafiltration, fluid as well as uhrafiltration should be supplemented to increase the transmembrane pressure.
10.The effects of Shadu Cao Mixture on immune functions of immunosuppression mice.
Shun-fei LU ; Liang-liang WANG ; Jun-wan LU ; Bing-jin LIU ; Ying-peng TONG ; Xiao-dong CHENG ; Ting-mei YE
Chinese Journal of Applied Physiology 2015;31(3):266-269
OBJECTIVETo investigate the effects of Shadu Cao Mixture (SDCM, traditional Chinese medicine) on immune functions of immunosuppression mice.
METHODSFifty BALB/C mice were randomly divided into blank control group, model group, SDCM low-dose, middle-dose and high-dose group. Except the blank control group, other groups were intraperitoneal injected with cyclophosphamide (40 mg/kg) to establish immunosuppression mice model. The blank control group and model group received gavage administration with nonnal saline, while the other groups received gavage administration with different doses of SDCM (10, 20, 40 m/kg for 15 days) respectively. The number of leukocytes and serum levels of interleukin-2 (IL-2), tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) in peripheral blood, spleen index, and the function of NK cells were measured.
RESULTSCompared with the model group , SDCM increased the number of leukocytes and serum concentrations of IL-2, TNF-α and IFN-γ in peripheral blood and improved the spleen index and the function of NK cells significantly (P < 0.05-0.01).
CONCLUSIONSDCM could remarkably enhance the immune functions of immunosuppression mice induced by cyclophosphamide.
Animals ; Cyclophosphamide ; Disease Models, Animal ; Drugs, Chinese Herbal ; pharmacology ; Immunosuppression ; Interferon-gamma ; blood ; Interleukin-2 ; blood ; Killer Cells, Natural ; immunology ; Mice ; Mice, Inbred BALB C ; Spleen ; immunology ; Tumor Necrosis Factor-alpha ; blood